Cargando…
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection
BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) pandemic has caused a significant impact on all aspects of life. One of the comorbidities associated with severe outcome and mortality of COVID-19 is diabetes. Metformin is one of the drugs which is most commonly used for the treatment of...
Autores principales: | Hariyanto, Timotius Ivan, Kurniawan, Andree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434427/ https://www.ncbi.nlm.nih.gov/pubmed/32844132 http://dx.doi.org/10.1016/j.obmed.2020.100290 |
Ejemplares similares
-
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020) -
Authors’ response: Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19)
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)